Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Catheter Precision (VTAK) Long-Term Debt Issuances (2024 - 2026)

Catheter Precision (VTAK) reported Long-Term Debt Issuances of $835000.0 for Q1 2026, up 178.33% on a QoQ basis from $300000.0 in Q4 2025.

Catheter Precision (VTAK) has 3 years of Long-Term Debt Issuances data on file, last reported at $835000.0 in Q1 2026.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to $835000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 33.53% YoY) and the FY2025 annual result came in at $300000.0, down 80.0% from the prior year.
  • Long-Term Debt Issuances improved to $835000.0 in Q1 2026 per VTAK's latest filing, from $300000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $850000.0 in Q3 2024 and bottomed at $300000.0 in Q4 2025.
  • The 3-year median for Long-Term Debt Issuances is $835000.0 (2026), against an average of $661666.7.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Catheter Precision 2.01 Mn 1.20 Mn 390,000.00 835,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 835,000.00
Mar 31, 2026 835,000.00
Dec 31, 2025 300,000.00
Dec 31, 2025 300,000.00
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Dec 31, 2024 1.25 Mn
Dec 31, 2024 1.25 Mn
Sep 30, 2024 -401,000.00
Sep 30, 2024 -401,000.00